EUVIMEDEUVIMED entdecken
Crossref

Unraveling the mechanisms of Schisandra Chinensis Mixture against diabetic nephropathy by integrating serum pharmacochemistry, network pharmacology, transcriptomics, and metabolomics

Yuan-Yuan Deng, Yu Ma, Yi-Xuan Wang, Lu-Yao Wang, Xin-Yu Ma, Jiang-Yuan Jin, Ni Tian, Shao-Ning Dong, Sai Zhang, Min-Ying Zhang, Mian-Zhi Zhang

Journal of Ethnopharmacology · 2026

DOI: 10.1016/j.jep.2025.120983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2026. Verfasst von Yuan-Yuan Deng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, China; Second Clinical Medical College, Beijing…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Schisandra, Drugs, Chinese Herbal, Diabetes Mellitus, Experimental. Die Arbeit nennt 82 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Schisandra Chinensis Mixture (SM), a classic TCM formula derived from Bugan Decoction in Zhang Sanxi's Medical Essentials in Six Parts (1615 CE), has demonstrated efficacy in treating diabetic nephropathy (DN), though its underlying mechanisms await full elucidation. AIM OF THE STUDY: To decipher the specific composition of SM and its synergistic mechanisms against DN, focusing on ferroptosis regulation, using an integrative multi-omics approach. MATERIALS AND METHODS: The bioactive components absorbed into the bloodstream (serum pharmacochemistry) after SM administration were identified using UPLC-ESI-MS/MS. Network pharmacology was employed to predict the main therapeutic targets and biological pathways related to SM's anti-DN effects. Molecular docking and surface plasmon resonance (SPR) assays validated interactions between key SM components and core target proteins. A DN rat model was established using a high-sugar, high-fat diet combined with streptozotocin injection. The effectiveness of SM in safeguarding the kidneys was evaluated by the renal index, liver and kidney function, blood glucose and lipid levels, histological analysis, and ferroptosis-related indices in renal tissue. To clarify the mechanism of SM, a combined analysis of metabolomics and transcriptomics was conducted, revealing changes in glycerophospholipid metabolism and the inhibition of ferroptosis. Key findings from multi-omics, serum pharmacochemistry, and network pharmacology were further validated using RT-PCR, western blot, ELISA, immunofluorescence (IF), and immunohistochemistry (IHC). RESULTS: 22 prototype compounds derived from SM were characterized using serum pharmacochemistry. Using network pharmacology, we identified 206 common targets of SM for DN treatment. Notably, protein-protein interaction and enrichment analyses highlighted mitochondrial energy restoration, atherosclerosis, lipid metabolism disorders, and ferroptosis as key mechanisms underlying the anti-DN effects of SM. According to molecular docking and SPR analyses, the principal components strongly bind to the core targets. Pharmacodynamic studies indicated that SM significantly enhanced liver and kidney function, improved lipid metabolism indices, and ameliorated pathological characteristics in DN. SM aided in restoring mitochondrial structure and function while also inhibiting oxidative stress and ferroptosis phenotypes. Integrated metabolomics and transcriptomics analyses revealed significant disruptions in the glycerophospholipid metabolism pathway in DN rats, which SM was able to rectify, thereby restoring the lipid metabolic balance impaired by DN. Further validation through RT-PCR, western blot, ELISA, IF, and IHC experiments confirmed SM's capacity to restore mitochondrial structure and function, reduce lipid peroxidation, and inhibit ferroptosis in DN by regulating key genes, enzymes and metabolites in the glycerophospholipid metabolism pathway. CONCLUSIONS: This study provides initial insights into the mechanism through which SM may inhibit ferroptosis in DN, potentially involving glycerophospholipid reprogramming to support mitochondrial integrity. Our observations contribute to a broader understanding of relevant metabolic pathways and key genes associated with this process. The methodological framework applied here helps clarify the multi-compartmental suppression of lipid peroxidation by SM, laying a tentative foundation for future research on phytotherapeutic strategies targeting ferroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesSchisandraDrugs, Chinese HerbalDiabetes Mellitus, ExperimentalAnimalsNetwork PharmacologyMetabolomicsMaleRatsRats, Sprague-DawleyTranscriptomeMolecular Docking SimulationKidneyFerroptosis

Stichwörter der Autor:innen

Diabetic nephropathyFerroptosisGlycerophospholipid metabolismMetabolomicsNetwork pharmacologySchisandra chinensis mixtureSerum pharmacochemistryTranscriptomics

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Nephrology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, China; Second Clinical Medical College, Beijing University of Chinese Medicine, Beijing, 100029, China.
  • Department of Nephrology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, China.
  • The Graduate School, Tianjin Medical University, Tianjin, 300070, China.
  • Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
  • Department of Nephrology, Tianjin Academy of Traditional Chinese Medicine, Tianjin, 300120, China.
  • School of Medicine, Nankai University, Tianjin, 300071, China. Electronic address: zhangminying@nankai.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Deng, Y. Y., Ma, Y., Wang, Y. X., Wang, L. Y., Ma, X. Y., Jin, J. Y., Tian, N., Dong, S. N., Zhang, S., Zhang, M. Y., & Zhang, M. Z. (2026). Unraveling the mechanisms of Schisandra Chinensis Mixture against diabetic nephropathy by integrating serum pharmacochemistry, network pharmacology, transcriptomics, and metabolomics. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.120983

Vancouver

Deng YY, Ma Y, Wang YX, Wang LY, Ma XY, Jin JY, et al. Unraveling the mechanisms of Schisandra Chinensis Mixture against diabetic nephropathy by integrating serum pharmacochemistry, network pharmacology, transcriptomics, and metabolomics. Journal of Ethnopharmacology. 2026. doi:10.1016/j.jep.2025.120983

BibTeX
@article{Deng2026,
  author = {Deng, Yuan-Yuan and Ma, Yu and Wang, Yi-Xuan and Wang, Lu-Yao and Ma, Xin-Yu and Jin, Jiang-Yuan and Tian, Ni and Dong, Shao-Ning and Zhang, Sai and Zhang, Min-Ying and Zhang, Mian-Zhi},
  title = {Unraveling the mechanisms of Schisandra Chinensis Mixture against diabetic nephropathy by integrating serum pharmacochemistry, network pharmacology, transcriptomics, and metabolomics},
  journal = {Journal of Ethnopharmacology},
  year = {2026},
  doi = {10.1016/j.jep.2025.120983}
}
Kostenlos starten →